Fidelity Investments’s Xtant Medical Holdings XTNT Stock Holding History

Fidelity Investments’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-500	Closed	-$279	–	5735
2026 Q1	$279	Buy	+500	New	+$308	﹤0.01%	5207
2024 Q2	–	Sell	-1,132	Closed	-$1.32K	–	5667
2024 Q1	$1.32K	Hold	1,132	–	–	﹤0.01%	4757
2023 Q4	$1.28K	Buy	1,132 +1,048	+1,248%	+$1.23K	﹤0.01%	4719
2023 Q3	$92	Buy	84 +31	+58%	+$33	﹤0.01%	4869
2023 Q2	$49	Sell	53 -35	-40%	-$23	﹤0.01%	5021
2023 Q1	$56	Buy	+88	New	+$64	﹤0.01%	4964
2022 Q4	–	Sell	-100	Closed	–	–	5616
2022 Q3	$0	Buy	+100	New	+$55	﹤0.01%	5475

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments's XTNT Position: Q2 2026 in Review

Fidelity Investments sold out of Xtant Medical Holdings (XTNT) in Q2 2026, closing a stake of 500 shares — an estimated $279 sold.

Fidelity Investments first reported a position in XTNT in Q3 2022 and held it in 7 quarters. The position peaked at $1.32K in Q1 2024. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Fidelity Investments reported no remaining Xtant Medical Holdings position as of Q2 2026 after selling out during the quarter.
Fidelity Investments sold 500 Xtant Medical Holdings shares in Q2 2026, an estimated $279.
Fidelity Investments first reported a position in Xtant Medical Holdings in Q3 2022 and held it in 7 quarters.
Fidelity Investments's Xtant Medical Holdings position peaked at $1.32K in Q1 2024.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.